Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Cell Adhesion in Plants01:14

Cell Adhesion in Plants

2.4K
Plants have rigid cell walls that are made up of cell wall polysaccharides that mediate cell-cell adhesion. The primary cell walls of plants consist of two independent and interacting polysaccharide networks: a pectin matrix that embeds the second network comprising cellulose and hemicelluloses.
Pectins are complex heteropolymers mainly composed of negatively-charged α-D-glucopyranosyl uronic acid and some neutral glycosyl residues such as α-L-rhamnopyranose, α-L-arabinofuranose,...
2.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.6K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absence of EOGT precludes defective development in fringe-null mouse intestine.

Biochimica et biophysica acta. General subjects·2026
Same author

Absence of EOGT Precludes Defective Development in Fringe-null Mouse Intestine.

bioRxiv : the preprint server for biology·2026
Same author

Absence of the dolichol synthesis gene DHRSX leads to N-glycosylation defects in Lec5 and Lec9 Chinese hamster ovary cells.

The Journal of biological chemistry·2024
Same author

Deletion of <i>Mgat2</i> in spermatogonia blocks spermatogenesis.

Frontiers in cell and developmental biology·2024
Same author

The N-glycosylation defect in Lec5 and Lec9 CHO cells is caused by absence of the DHRSX gene.

bioRxiv : the preprint server for biology·2024
Same author

Genetics of glycosylation in mammalian development and disease.

Nature reviews. Genetics·2024
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K

Galectin-1 Pulls the Strings on VEGFR2.

Pamela Stanley1

  • 1Department Cell Biology, Albert Einstein College Medicine, New York, NY 10461, USA.

Cell
|February 18, 2014
PubMed
Summary
This summary is machine-generated.

Galectin-1 drives tumor growth by keeping VEGF receptor 2 on cell surfaces, promoting blood vessel formation independently of VEGF. This discovery offers new insights into resistance against anti-angiogenesis cancer therapies.

More Related Videos

Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing
09:59

Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing

Published on: October 11, 2021

3.0K
A Method for Labeling Vasculature in Embryonic Mice
09:58

A Method for Labeling Vasculature in Embryonic Mice

Published on: October 7, 2011

15.4K

Related Experiment Videos

Last Updated: May 3, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K
Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing
09:59

Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing

Published on: October 11, 2021

3.0K
A Method for Labeling Vasculature in Embryonic Mice
09:58

A Method for Labeling Vasculature in Embryonic Mice

Published on: October 7, 2011

15.4K

Area of Science:

  • Oncology
  • Immunotherapy
  • Molecular Biology

Background:

  • Anti-vascular endothelial growth factor (VEGF) cancer immunotherapy is a key strategy targeting tumor angiogenesis.
  • Resistance to anti-VEGF therapies is a significant clinical challenge, limiting treatment efficacy.
  • Understanding resistance mechanisms is crucial for developing more effective cancer treatments.

Purpose of the Study:

  • To elucidate the mechanisms by which galectin-1 contributes to resistance in anti-VEGF cancer immunotherapy.
  • To investigate the role of galectin-1 in regulating VEGF receptor 2 (VEGFR2) and tumor angiogenesis.
  • To identify novel therapeutic targets for overcoming resistance to anti-angiogenesis treatments.

Main Methods:

  • Investigated the interaction between galectin-1 and VEGFR2 on cancer cell surfaces.
  • Utilized molecular biology techniques to study VEGFR2 cell-surface retention.
  • Assessed the impact of galectin-1 on VEGF-independent tumor angiogenesis in preclinical models.

Main Results:

  • Galectin-1 was found to prolong the cell-surface retention of VEGFR2.
  • This prolonged retention stimulates tumor angiogenesis independently of VEGF.
  • Identified a complex interplay of mechanisms contributing to therapeutic resistance.

Conclusions:

  • Galectin-1 plays a critical role in promoting tumor angiogenesis and resistance to anti-VEGF therapy.
  • Targeting galectin-1 or its downstream effects could be a promising strategy to overcome resistance.
  • This study reveals novel insights into the molecular basis of resistance in cancer immunotherapy.